IDEXX Laboratories, Inc. (IDXX)
NASDAQ·Healthcare·Medical - Diagnostics & Research
$568.32
-1.15%
Mkt Cap $46.43B
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Feb 2, 2026 | $1.07B | $1.09B | +1.67% | $2.93 | $3.08 | +5.12% | — | — |
| Q4 2025 Nov 3, 2025 | $1.07B | $1.11B | +2.98% | $3.14 | $3.40 | +8.28% | — | — |
| Q3 2025 Aug 4, 2025 | $1.06B | $1.11B | +4.43% | $3.28 | $3.63 | +10.67% | — | — |
| Q2 2025 May 1, 2025 | $997.10M | $998.43M | +0.13% | $2.85 | $2.96 | +3.86% | — | — |
| Q1 2025 Feb 3, 2025 | $935.15M | $954.29M | +2.05% | $2.39 | $2.62 | +9.62% | — | — |
| Q4 2024 Oct 31, 2024 | $980.32M | $975.54M | -0.49% | $2.68 | $2.80 | +4.48% | — | — |
| Q3 2024 Aug 6, 2024 | $1.01B | $1.00B | -0.31% | $2.88 | $3.02 | +4.86% | — | — |
| Q2 2024 May 1, 2024 | $964.41M | $964.10M | -0.03% | $2.67 | $2.81 | +5.24% | — | — |
| Q1 2024 Feb 5, 2024 | $891.25M | $901.60M | +1.16% | $2.12 | $2.32 | +9.43% | — | — |
| Q4 2023 Nov 1, 2023 | $926.76M | $915.53M | -1.21% | $2.37 | $2.53 | +6.75% | — | — |
| Q3 2023 Aug 1, 2023 | $934.42M | $943.63M | +0.99% | $2.47 | $2.67 | +8.10% | — | — |
| Q2 2023 May 2, 2023 | $892.47M | $900.20M | +0.87% | $2.42 | $2.55 | +5.37% | — | — |
| Q1 2023 Feb 6, 2023 | $820.91M | $828.57M | +0.93% | $1.94 | $2.05 | +5.67% | — | — |
| Q4 2022 Nov 1, 2022 | $830.00M | $841.66M | +1.40% | $2.04 | $2.15 | +5.39% | — | — |
| Q3 2022 Aug 2, 2022 | $863.14M | $860.55M | -0.30% | $1.56 | $1.56 | +0.00% | — | — |
| Q2 2022 May 4, 2022 | $837.10M | $836.55M | -0.07% | $2.26 | $2.27 | +0.44% | — | — |
| Q1 2022 Feb 2, 2022 | $781.83M | $801.09M | +2.46% | $1.71 | $1.89 | +10.53% | — | — |
| Q4 2021 Nov 2, 2021 | $797.10M | $810.42M | +1.67% | $1.91 | $2.03 | +6.28% | — | — |
| Q3 2021 Jul 30, 2021 | $786.32M | $826.14M | +5.06% | $2.02 | $2.34 | +15.84% | — | — |
| Q2 2021 May 4, 2021 | $740.74M | $777.71M | +4.99% | $1.72 | $2.35 | +36.63% | — | — |